VAMICONSUL
Last board
4 directors, 1 in day-to-day management, last change in 2024Director
since 27-06-2024
term without a fixed end
listed in the 2024 annual accounts, filed on 20-05-2025
Director
since 27-06-2024
term without a fixed end
listed in the 2024 annual accounts, filed on 20-05-2025
Director
since 27-06-2024
term without a fixed end
listed in the 2024 annual accounts, filed on 20-05-2025
Director and managing director
director since 27-06-2024
managing director appointed by deed of 21-08-2024
term without a fixed end
listed in the 2024 annual accounts, filed on 20-05-2025
Mandates through the years
6 names, the dashed line is todayDirector
Director
Director
Director, Managing director
Director
Director
LeadershipBoardEarliermandate already running before its first mention
Mandates as a list
-
- Director, from 27-06-2024 to date
-
- Director, from 27-06-2024 to date
-
- Director, from 27-06-2024 to date
-
- Director, from 27-06-2024 to date
- Managing director, appointed by deed of 21-08-2024, still in office
-
- Director, from before 31-12-2021 to 21-08-2024
-
- Director, until 24-04-2023
Control
Parent
Equity €4.1m
Profit €2,579 in 2024
Source: deed 11-08-2025
100%
This company
VAMICONSUL
Equity €22,408
Profit €6,042 in 2024
Capital
- Contribution
- €13,100
- Shares
- 200
- Contribution per share
- €65.50
- Equity per share
- €112 in 2024
- Source
- 2024 annual accounts
Owners through the years
as the annual accounts name themSource: lists of holdings in the owners' accounts
Articles of association
deed of 24-04-2023 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Second Friday of June at 18:00
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 11-08-2025 ↗
- all shares
Stated in the deed
deed of 22-05-2025 ↗
- 100%
Capital over time
- 22-05-2025 Capital stated in the deed · 200 shares